AVET |
AV-60002

Juraclox LA600 200's

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
For the treatment of bovine mastitis caused by organisms sensitive to cloxacillin during the dry period

Active Constituent(s)
Cloxacillin (as benzathine) 600 mg

Indications
For use by or under direction of a veterinarian.
For the treatment of bovine mastitis caused by organisms sensitive to cloxacillin during the dry period.
For the control in dairy cows of mastitis. The product is active against Gram-positive organisms associated with mastitis, including Streptococcus spp., penicillin resistant and sensitive Staphylococcus spp., Trueperella (Corynebacterium) pyogenes and other species susceptible to cloxacillin.
Indiscriminate use of elevet+ Juraclox L.A 600 Dry Cow Long Acting Intramammary Suspension could contribute to the development of antibiotic resistance

Dosage and Administration
Dose: One syringe per quarter immediately after the final milking of a lactation.

Administration:
At the final milking of a lactation, milk the cow normally. Clean and disinfect the teat ends using rubbing alcohol or iodophors or other suitable disinfectant. Infuse the contents of one syringe into each quarter and leave without further milking. Treatment can be followed by administration of an internal teat sealant, such as elevet+ U-Seal (APVMA: 86556). Refer to the elevet+ U-Seal label for directions for use. Wear clean rubber gloves when applying. Dip all teats in an approved teat disinfectant after infusion.

Contraindications
DO NOT USE in lactating cows or within 35 days of calving.
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Categorisation:
Prescription